Study Watch vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Verily Life Sciences
VS
by Powerful Medical

AI Verdict

Verily Study Watch is a wearable device primarily designed for continuous physiological monitoring in clinical research, collecting various data points including ECG, heart rate, and movement for analysis in a cloud platform. PMcardio, on the other hand, is an AI platform that interprets existing 12-lead ECGs to assess over 50 cardiac conditions, acting as a clinical decision support tool for healthcare professionals at the point of care. While both deal with cardiac data and AI, Study Watch focuses on data *collection* for research, whereas PMcardio focuses on AI-powered *interpretation* of ECGs for clinical diagnosis.

Choose Study Watch if…

Choose Verily Study Watch if you are conducting clinical research that requires continuous, non-invasive physiological monitoring over extended periods. Its long battery life and multiple sensors make it ideal for collecting rich, complex datasets in observational studies, such as those investigating Parkinson's disease progression or drug efficacy. The device is prescription-only and designed for research, not consumer use, ensuring data integrity for clinical trials.

View Study Watch →

Choose PMcardio if…

Choose PMcardio if you need rapid, AI-powered interpretation of 12-lead ECGs at the point of care, especially in emergency or acute settings. Its ability to detect over 50 cardiac conditions, including subtle STEMI/OMI and reduced LVEF, with high accuracy can empower various healthcare professionals to make confident, time-critical clinical decisions and improve patient outcomes.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Study Watch PMcardio
Pricing Not publicly available (device for clinical research and partnerships) Freemium
Deployment Cloud (data uploaded from device to Verily's cloud platform). Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status Yes AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers a mobile app and web platform, allowing for immediate use without IT integration, and features like ECG digitization from images enhance its practicality in diverse clinical settings. Verily Study Watch, while designed for unobtrusive data collection in research, is a prescription-only device primarily for clinical studies and partnerships, suggesting a more specialized and less broadly accessible user experience.

Clinical Value

PMcardio

PMcardio is a CE-certified AI platform that interprets ECGs for over 50 cardiac conditions, with clinical validation in more than 25 studies, demonstrating high accuracy for conditions like STEMI/OMI and reduced LVEF. Verily Study Watch is a prescription-only wearable for continuous physiological monitoring in clinical research, with FDA clearance for single-channel ECG and irregular pulse monitoring, and studies showing its use in detecting atrial fibrillation and assessing heart failure risk.

Pricing & Value

PMcardio

PMcardio offers a freemium model with a free plan for 5 ECG analyses per month and a transparent Pro Plan for unlimited use, providing clear value propositions for individual clinicians and organizations. Verily Study Watch's pricing is not publicly available as it's primarily for clinical research and partnerships, making its value proposition less accessible for general clinical use.

Enterprise Readiness

PMcardio

PMcardio is built for regulated healthcare environments, with SOC 2 Type II, ISO 27001, GDPR, and HIPAA compliance, and offers enterprise integrations with EHR/CVIS and EMS systems. Verily Study Watch is designed for clinical research and partnerships, with data uploaded to Verily's cloud platform, and while Verily states HIPAA adherence, an ongoing lawsuit alleges breaches.

Innovation

PMcardio

PMcardio features visual AI explainability with heatmaps (ECGxplainu2122) and specialized AI models like Queen of Heartsu2122 for STEMI/OMI detection and LVsenseu2122 for reduced LVEF, showcasing advanced AI application in ECG interpretation. Verily Study Watch offers continuous physiological monitoring with multiple sensors and cloud-based data processing with algorithms and machine learning, focusing on unobtrusive data collection for research.

Support & Docs

PMcardio

PMcardio provides a comprehensive Trust Center with detailed compliance information, security protocols, and certifications, along with a Help Center, FAQ, and research publications. Verily Study Watch, being a research-focused device, has documentation primarily geared towards clinical studies and partnerships, with less publicly available information on general user support beyond research contexts.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Study Watch PMcardio
Name Study Watch PMcardio
Company Verily Life Sciences Powerful Medical
Description Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately.
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI, Clinical Decision Support & Reference
Specialties Cardiology, Neurology, Sleep Medicine Cardiology, Emergency Medicine, Internal Medicine
Key Features (Examples) Continuous physiological monitoring, Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements), Long battery life (up to one week) Instant AI-powered ECG interpretations, Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Queen of Heartsu2122 - STEMI and OMI Detection

Videos

Demos, reviews, and walkthroughs featuring Study Watch and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, designed to connect to existing ECG systems and hospital systems, allowing results to flow automatically without manual uploads. Verily Study Watch, as a prescription-only device for clinical research, collects data that is analyzed in Verily's cloud platform, and Verily is working on integrating mobile health data into the clinical care environment and connecting with EHR data.
PMcardio has been clinically validated in over 25 studies, demonstrating 86% sensitivity and 92% specificity for major ECG abnormalities, and near-perfect accuracy for atrial fibrillation (97% sensitivity and 99% specificity). Its Queen of Heartsu2122 AI model for STEMI detection correctly identified 92% of true STEMIs in a study, compared to 71% by standard triage methods, and reduced false activations by 90%. Verily Study Watch provides accurate single-channel ECG waveform display, with clinical performance testing showing qualitative clinical equivalence and inter-beat interval Bland-Altman analysis with a bias of 1.2ms when compared to industry-standard 12-lead ECG devices.
Verily Study Watch is primarily designed for clinical research and continuous physiological monitoring in specialties like Cardiology, Neurology, and Sleep Medicine, with applications in Parkinson's studies and heart failure risk assessment. PMcardio is geared towards Cardiology, Emergency Medicine, and Internal Medicine, providing instant AI-powered ECG interpretations for over 50 cardiac conditions, including STEMI/OMI, rhythms, and reduced LVEF, and offers clinical suites for acute care, echo screening, remote monitoring, and angiography.
PMcardio offers a help center for individuals, including troubleshooting FAQs and instructions for use, and provides email support. For organizations, PMcardio offers dedicated onboarding sessions and priority email support. Verily provides contact information for inquiries about the Study Watch and its solutions for life sciences.
PMcardio for Organizations includes features to track pathway performance across sites and teams, with dashboards and reporting to support QA, audits, protocol optimization, and registry compliance. Verily's platform is designed to support clinical research, which typically involves rigorous data logging and audit trails, though specific audit-trail features for the Study Watch were not detailed in the provided information.
PMcardio for Organizations is built for enterprise-ready deployment and scales across campuses and care settings without custom builds, connecting to existing ECG systems, EHR/CVIS, and EMS systems. It is purpose-built for multi-pathway, multi-site cardiac care delivery, bringing interoperability, decision support, escalation, outcomes intelligence, and governance into one platform. Verily Study Watch is used in large-scale clinical research studies, and Verily's collaborations aim to integrate wearable data with clinical research infrastructure to support real-world studies.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.